InvestorsHub Logo
Followers 14
Posts 2860
Boards Moderated 0
Alias Born 12/23/2014

Re: TheHappyVulcan post# 2170

Tuesday, 06/26/2018 5:16:57 PM

Tuesday, June 26, 2018 5:16:57 PM

Post# of 2463
Vulcan - I went back and reviewed the presentation by Goldberger. see slide 14 for potential new markets.

http://www.rmsmedicalproducts.com/wp-content/uploads/2018/06/repr-1q18-presentation.pdf

Additionally some drugs that were traditionally delivered by IV, can now be self administer at home via the RMS home infusion system. This is possible because of the new administration set with the patent pending needles.

There are many sexier technologies but REPR is a small company and has no long term debt. The company can finance its growth without issuing more shares. I expect the company will eventually be bought out at two or more times the current share price.